StockWatch
·

AARTI DRUGS LTD.

BSE: 524348

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-59.80200.76461.31721.87Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
2.426.8711.3215.77Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue631.68+19.5%528.80-8.7%578.95+11.1%520.96-16.4%622.96+21.1%514.54-5.3%543.09
Other Income0.83-32.0%1.22+713.3%0.15-60.5%0.38-77.8%1.71-85.0%11.37+2892.1%0.38
Total Income632.51+19.3%530.02-8.5%579.10+11.1%521.34-16.5%624.67+18.8%525.91-3.2%543.47
EXPENSES
Expenditure573.95+12.9%508.31-2.9%523.32+9.9%476.09-14.1%554.00+16.9%473.88-5.7%502.58
Tax13.60+212.1%-12.13-186.6%14.00+513.0%-3.39-136.9%9.19-31.9%13.50+28.6%10.50
PROFIT
PBT58.56+169.7%21.71-61.1%55.78+23.3%45.25-36.0%70.67+35.8%52.03+27.2%40.89
Net Profit44.96+32.9%33.84-19.0%41.78-14.1%48.64-20.9%61.48+59.6%38.53+26.8%30.39
KEY METRICS
OPM %12.55%+4.55pp8.00%-4.99pp12.99%+0.71pp12.28%-1.95pp14.23%+10.14pp4.09%+0.13pp3.96%
NPM %7.11%+0.73pp6.38%-0.83pp7.21%-2.12pp9.33%-0.51pp9.84%+2.51pp7.33%+1.74pp5.59%
EPS4.93+32.9%3.71-19.0%4.58-14.1%5.33-20.9%6.74+59.7%4.22+26.7%3.33

Corporate Events

DividendAARTIDRUGS
2026
9Feb

₹2 / share

BSE Filing
Board MeetingAARTIDRUGS
2026
3Feb

Board Meeting

Consider and approve Audited Financial Results (Standalone a…

BSE Filing
Board MeetingAARTIDRUGS
2025
18Jul

Board Meeting

Consider and approve Audited financial results

BSE Filing
DividendAARTIDRUGS
2025
4Feb

₹1 / share

BSE Filing
Board MeetingAARTIDRUGS
2024
24Oct

Board Meeting

Audited financial results, Consider, Approve, Take on record

BSE Filing
Board MeetingAARTIDRUGS
2024
26Aug

Board Meeting

Buyback of equity shares

BSE Filing
Board MeetingAARTIDRUGS
2024
3May

Board Meeting

consider and approve Audited Financial Results

BSE Filing
DividendAARTIDRUGS
2024
6Feb

₹1 / share

BSE Filing
Board MeetingAARTIDRUGS
2024
24Jan

Board Meeting

Consider and approve Quarterly Audited Financial results for…

BSE Filing
Board MeetingAARTIDRUGS
2023
19Oct

Board Meeting

Consider and approve Audited Financial Results for the quart…

BSE Filing